Glycine vs Taurine
Two cheap amino acids, each carrying an animal lifespan result and a human story that does not follow from it. The limits are different, and they matter.
Short answer
The evidence gap decides this one. Glycine has human clinical data behind it, while taurine has only preclinical or minimal evidence, resting mostly on animal or lab work. Someone focused on sleep quality, collagen support and glutathione has trial data to go on with glycine; taurine, marketed for longevity and healthspan, is still an early-research option.
Glycine
Aminoacetic acid, Gly
A genuine 4–6% lifespan result in the ITP and Mendelian-randomization support for lower coronary risk — but the human sleep evidence comes from a single corporate lab and there is no collagen outcome trial at all.
Full Glycine evidence reviewTaurine
Reversed aging markers and extended lifespan in animals (Singh 2023), with a human association — but no human outcome trial yet.
Full Taurine evidence reviewGlycine vs Taurine: head to head
- FDA status / approved use
Glycine
Sold as a dietary supplement; not FDA-approved to treat insomnia or any other conditionTaurine
Cheap amino acid sold as a supplement and found in energy drinks- Marketed for
Glycine
Sleep quality, collagen support, glutathione, healthy agingTaurine
Longevity, healthspan- Outcome areas
Glycine
Longevity / lifespan; Sleep; Cardiovascular; Skin / hairTaurine
Longevity / lifespan- Evidence grade
Glycine
Clinical dataTaurine
Preclinical / minimal- How it works
Glycine
Acts as an NMDA co-agonist in the brain clock, lowering core temperature before sleepTaurine
Proposed to replace taurine lost with age, though human levels may not decline- Route and dosing
Glycine
Oral powder, typically 3 g shortly before bed for sleepTaurine
Oral supplement, taken daily (1.6 g/day in one trial)- Headline human result
Glycine
3 g before bed reduced next-day fatigue after sleep restriction in a company-run trial with 7 men analyzedTaurine
Systolic pressure fell 7.2 mmHg vs 2.6 on placebo over 12 weeks at 1.6 g/day in 120 people with prehypertension- Strongest evidence
Glycine
ITP lifespan study, Aging Cell 2019Glycine evidence reviewPubMed 30916479Taurine
Animal + association, Science 2023. Little or no controlled human outcome data for the marketed useTaurine evidence reviewPubMed 37289866- Key safety signal
Glycine
Well tolerated; do not combine with clozapine; minor oxalate precursor for kidney-stone formersTaurine
Considered well tolerated, with a low downside to trying it- How it is obtained
Glycine
Over the counter as a dietary supplementTaurine
Over the counter as a dietary supplement
| Glycine | Taurine | |
|---|---|---|
| FDA status / approved use | Sold as a dietary supplement; not FDA-approved to treat insomnia or any other condition | Cheap amino acid sold as a supplement and found in energy drinks |
| Marketed for | Sleep quality, collagen support, glutathione, healthy aging | Longevity, healthspan |
| Outcome areas | Longevity / lifespan; Sleep; Cardiovascular; Skin / hair | Longevity / lifespan |
| Evidence grade | Clinical data | Preclinical / minimal |
| How it works | Acts as an NMDA co-agonist in the brain clock, lowering core temperature before sleep | Proposed to replace taurine lost with age, though human levels may not decline |
| Route and dosing | Oral powder, typically 3 g shortly before bed for sleep | Oral supplement, taken daily (1.6 g/day in one trial) |
| Headline human result | 3 g before bed reduced next-day fatigue after sleep restriction in a company-run trial with 7 men analyzed | Systolic pressure fell 7.2 mmHg vs 2.6 on placebo over 12 weeks at 1.6 g/day in 120 people with prehypertension |
| Strongest evidence | ITP lifespan study, Aging Cell 2019Glycine evidence reviewPubMed 30916479 | Animal + association, Science 2023. Little or no controlled human outcome data for the marketed useTaurine evidence reviewPubMed 37289866 |
| Key safety signal | Well tolerated; do not combine with clozapine; minor oxalate precursor for kidney-stone formers | Considered well tolerated, with a low downside to trying it |
| How it is obtained | Over the counter as a dietary supplement | Over the counter as a dietary supplement |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- Clinical data:
- Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).
- Preclinical / minimal:
- Evidence is largely animal, in-vitro, or anecdotal. Little or no controlled human outcome data for the marketed use.
Our verdict
Both have a real rodent lifespan finding and neither has a human outcome trial, so the honest comparison is what each result actually rests on. Glycine's is the sturdier kind: in the NIA Interventions Testing Program an 8% glycine diet extended median lifespan 4–6% in both male and female mice at all three sites — replicated across sites, at an intake roughly twenty times a human bedtime dose per kilogram. Taurine's comes from the 2023 Singh work in Science, where taurine declined with age across species and supplementation extended lifespan and healthspan markers in mice, but a 2025 analysis of longitudinal human and primate data found circulating taurine does not reliably decline with age in people, which undercuts the restore-what-you-lost premise rather than the mouse result itself. Neither borrows well from the other: glycine's human sleep evidence is small crossover work from a single corporate laboratory with no independent replication and no meta-analysis to pool, and taurine's human trials are modest cardiometabolic ones — lower blood pressure and improved vascular function in prehypertension, with cognitive effects rated limited and inconclusive.
Glycine fits if
Glycine is the more defensible cheap experiment for someone targeting sleep onset or covering a plausible dietary shortfall, on the understanding that the collagen claim has no human outcome trial behind it at all.
Taurine fits if
Taurine suits someone focused on blood pressure and vascular measures, where the small randomized signal is real, and who reads the anti-aging framing as mouse data resting on a human premise that failed to replicate.
Glycine vs Taurine: common questions
- Is either glycine or taurine FDA-approved?
- No. Glycine is sold as a dietary supplement; not FDA-approved to treat insomnia or any other condition. Taurine is a cheap amino acid sold as a supplement and found in energy drinks.
- Which has stronger human evidence, glycine or taurine?
- Glycine. It has human clinical data (key source: ITP lifespan study, Aging Cell 2019), while taurine has only preclinical or minimal evidence (key source: Animal + association, Science 2023).
- What are the main safety concerns with glycine and taurine?
- Glycine is well tolerated; do not combine with clozapine; minor oxalate precursor for kidney-stone formers. Taurine is considered well tolerated, with a low downside to trying it.
Key studies behind each
Glycine
- Meléndez-Hevia E, De Paz-Lugo P, Cornish-Bowden A, Cárdenas ML. (2009). A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis. J Biosci. PubMed 20093739
- de Paz-Lugo P, Lupiáñez JA, Meléndez-Hevia E. (2018). High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. Amino Acids. PubMed 30006659
- Bannai M, Kawai N. (2012). New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J Pharmacol Sci. PubMed 22293292
- Bannai M, Kawai N, Ono K, Nakahara K, Murakami N. (2012). The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Front Neurol. PubMed 22529837
Taurine
- Singh P, Gollapalli K, Mangiola S, et al. (2023). Taurine deficiency as a driver of aging. Science. PubMed 37289866
- Fernandez ME, et al. (2025). Is taurine an aging biomarker? Science. PubMed 40472098
- Sun Q, Wang B, Li Y, et al. (2016). Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study. Hypertension. PubMed 26781281
- Guan L, Miao P. (2020). The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials. Eur J Pharmacol. PubMed 32871172
The full evidence reviews
- Glycine: sleep, collagen, glutathione — and one real lifespan result
The simplest amino acid, and probably one you make too little of. The sleep trials are small and come from a single corporate lab; the mouse lifespan result is real but at twenty times a bedtime dose.
Updated August 2026
- Taurine and aging: what the Singh 2023 Science work and the human data actually show
A robust mouse lifespan result — but 2025 human data found taurine doesn't reliably decline with age, and the only human trials are small cardiometabolic ones.
Updated August 2026